At the time a diagnosis of epilepsy is made for a child, it is highly desirable to predict seizure control and social outcome several months or even years later. Determination of outcome is complex. This book is revolved around three main questions: - What is to be predicted? Is it seizure control, remission with or without ongoing AED treatment, intractability, social outcome or a combination? - What is the purpose of attempting prediction and who will use the information? - How accurate is the prediction? It takes a critical look at what is known about the outcome of childhood epilepsies, specifically evidence-based findings, and further clarifies the direction of clinical and fundamental research for the future.
This book gives an exhaustive account of the classification and management of epileptic disorders. It provides clear didactic guidance on the diagnosis and treatment of epileptic syndromes and seizures through thirteen chapters, complemented by a pharmacopoeia and CD ROM of video-EEGs.
The aim of this book is to take a critical look at what is known about outcome of childhood epilepsies, specifically evidence-based findings, and further clarify the direction of clinical and fundamental research for the future. At the time a diagnosis of epilepsy is made for a child, it is highly desirable to predict seizure control and social outcome several months or even years later. Determination of outcome is, however, complex and in order to confront this challenge, a number of simple questions should be addressed: What is to be predicted? This may be seizure control, remission with or without ongoing AED treatment, intractability, social outcome, quality of life, or a combination of the above. What is the purpose of attempting to predict outcome and who will use the information? How accurate is the prediction?
Although epilepsy is one of the nation's most common neurological disorders, public understanding of it is limited. Many people do not know the causes of epilepsy or what they should do if they see someone having a seizure. Epilepsy is a complex spectrum of disorders that affects an estimated 2.2 million Americans in a variety of ways, and is characterized by unpredictable seizures that differ in type, cause, and severity. Yet living with epilepsy is about much more than just seizures; the disorder is often defined in practical terms, such as challenges in school, uncertainties about social situations and employment, limitations on driving, and questions about independent living. The Institute of Medicine was asked to examine the public health dimensions of the epilepsies, focusing on public health surveillance and data collection; population and public health research; health policy, health care, and human services; and education for people with the disorder and their families, health care providers, and the public. In Epilepsy Across the Spectrum, the IOM makes recommendations ranging from the expansion of collaborative epilepsy surveillance efforts, to the coordination of public awareness efforts, to the engagement of people with epilepsy and their families in education, dissemination, and advocacy for improved care and services. Taking action across multiple dimensions will improve the lives of people with epilepsy and their families. The realistic, feasible, and action-oriented recommendations in this report can help enable short- and long-term improvements for people with epilepsy. For all epilepsy organizations and advocates, local, state, and federal agencies, researchers, health care professionals, people with epilepsy, as well as the public, Epilepsy Across the Spectrum is an essential resource.
A good understanding of the long-term outcome of epileptic disorders that have begun in infancy or childhood allows the practitioner to choose the best medical management and to adjust it throughout the life of the patient. The identification of risk factors of poor outcome is crucial, the issue being to prevent or minimize their impacts by appropriate interventions. However, knowledge on the natural course and long-term outcome of pediatric epilepsies is fragmentary for a lot of them for reasons that the authors discuss in this chapter. After reviewing general considerations on outcome for the epilepsies persisting throughout life, the authors will discuss the present state of knowledge on specific aspects concerning some pediatric epilepsy syndromes. These disorders have been chosen because they are representative of the wide range of potential outcomes that can be observed in adults.
The ultimate reference book : the 5th updated edition of the famous “blue guide”. Incluided : A DVD with new sequences completes each chapter! Epileptology changes. The syndromic approach is completed by an etiological approach, based on the major advances in genetics and functional genetics. New entities have found their place, and a purely descriptive, “electroclinical” approach is no longer adapted in many circumstances. The 5th edition of the Blue Guide includes the most recent advances. It was necessary to justify the physiological, epidemiologic, genetic and therapeutic approaches and to consider them in the light of the new classification efforts, which are still in the making. Nevertheless, the description of epileptic syndromes, both classical and recent, remains at the core of this book.
Epilepsy is the most common neurological problem affecting children and adolescents, with an incidence rate of 1–2%. Diagnosing epilepsy in children is often complicated by age-dependent manifestations which can differ greatly from seizure disorders seen in adults. Thus, effective treatment and management depends on clinicians to establish an accurate diagnosis and choose appropriate therapy based on the likelihood of clinical benefit. Handbook of Pediatric Epilepsy will be a concise overview of seizures in infants, children, and adolescents, including a discussion of common types of seizure disorders, treatment options, recent drug developments, and evidence-based disease management guidelines.
